Background: Parkinson's disease is a common disorder that becomes more prevalent with
advanced age. The cardinal features are related to dopamine deficiency, arising from loss of …

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. The
exact causes of neuronal damage are unknown, but mounting evidence indicates that …

… models, the safety issue of these targets needs to be analyzed before entering into the
clinical trial phase. Moreover, the novel therapeutic targets discussed in the current review offer …

… before we conclude with a discussion of the potential of NTFs as a therapeutic target in PD.
… it a more attractive therapeutic target in PD, one with the ability perhaps to target both motor (…

… both familial forms of the disease and animal models places … disease is currently without a
cure and most therapies target … in disease pathogenesis and as a potential therapeutic target …

Parkinson's disease (PD) is the most common movement disorder and the second most common
neurodegenerative disease after Alzheimer's disease… an attractive target for therapeutic …

The zona incerta has recently become an important target for deep-brain stimulation (DBS)
in Parkinson’s disease (PD). The present review summarizes clinical, animal and anatomical …

… Ferroptosis as a therapeutic target in Parkinson's disease. Alterations in the iron regulatory
pathway and phospholipid oxidation are implicated in Parkinson's disease pathology. …

… in the etiopathology of Parkinson's disease (PD) and as a result new therapeutic targets for
… 2 (Nrf2), as a pharmacological target for neuroprotective therapy in PD. Data generated by …

Parkinson's disease (PD) is a common, progressive neurodegenerative disease characterised
by degeneration of nigrostriatal dopaminergic neurons, aggregation of α-synuclein and …